173 related articles for article (PubMed ID: 16173267)
1. Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report.
Benucci M; Li GF; Del Rosso A; Manfredi M
Clin Exp Rheumatol; 2005; 23(5):733. PubMed ID: 16173267
[No Abstract] [Full Text] [Related]
2. Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade.
Rech J; Ronneberger M; Englbrecht M; Finzel S; Katzenbeisser J; Manger K; Manger B; Schett G
Ann Rheum Dis; 2011 Feb; 70(2):390-2. PubMed ID: 20650873
[No Abstract] [Full Text] [Related]
3. Prolonged efficacy of infliximab for refractory adult-onset Still's disease.
Dilhuydy MS; Vatan R; Etienne G; Longy-Boursier M; Mercié P
Clin Exp Rheumatol; 2005; 23(1):121-2. PubMed ID: 15789901
[No Abstract] [Full Text] [Related]
4. [Longterm outcome of TNF blockade in adult-onset Still's disease].
Dechant C; Schauenberg P; Antoni CE; Kraetsch HG; Kalden JR; Manger B
Dtsch Med Wochenschr; 2004 Jun; 129(23):1308-12. PubMed ID: 15179590
[TBL] [Abstract][Full Text] [Related]
5. Canakinumab in a case of adult onset still's disease: efficacy only on systemic manifestations.
Lo Gullo A; Caruso A; Pipitone N; Macchioni P; Pazzola G; Salvarani C
Joint Bone Spine; 2014 Jul; 81(4):376-7. PubMed ID: 24462130
[No Abstract] [Full Text] [Related]
6. [Refractory adult-onset Still's disease].
Fain O; Rouaghe S; Stirnemann J
Rev Prat; 2010 Mar; 60(3):314. PubMed ID: 20402117
[No Abstract] [Full Text] [Related]
7. Biological treatment in adult-onset Still's disease.
Pouchot J; Arlet JB
Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):477-87. PubMed ID: 23040362
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of thalidomide in refractory adult Still's disease: a new case report.
Meaux-Ruault N; Magy N; Gil H; Dupond JL
Clin Exp Rheumatol; 2003; 21(2):272. PubMed ID: 12747295
[No Abstract] [Full Text] [Related]
9. [Biological treatment of rare inflammatory rheumatic diseases].
Baslund B
Ugeskr Laeger; 2008 Jun; 170(24):2150-2. PubMed ID: 18565301
[TBL] [Abstract][Full Text] [Related]
10. Adalimumab in the treatment of refractory adult-onset Still's disease.
Lee WS; Yoo SH; Ko RE; Yoo WH
Int J Rheum Dis; 2017 Nov; 20(11):1798-1799. PubMed ID: 24954877
[No Abstract] [Full Text] [Related]
11. Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD).
Yoshimura M; Makiyama J; Koga T; Miyashita T; Izumi Y; Torigoshi T; Motokawa S; Eguchi K; Migita K
Clin Exp Rheumatol; 2010; 28(1):141-2. PubMed ID: 20346255
[No Abstract] [Full Text] [Related]
12. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases.
Fautrel B; Sibilia J; Mariette X; Combe B;
Ann Rheum Dis; 2005 Feb; 64(2):262-6. PubMed ID: 15184196
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of sarilumab in adult-onset Still's disease as a corticosteroid-sparing agent.
Simeni Njonnou SR; Soyfoo MS; Vandergheynst FA
Rheumatology (Oxford); 2019 Oct; 58(10):1878-1879. PubMed ID: 31056689
[No Abstract] [Full Text] [Related]
14. Adult onset Still's disease: response to Enbrel.
Asherson RA; Pascoe L
Ann Rheum Dis; 2002 Sep; 61(9):859-60; author reply 860. PubMed ID: 12176823
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of biological agents in adult-onset Still's disease.
Cavalli G; Franchini S; Aiello P; Guglielmi B; Berti A; Campochiaro C; Sabbadini MG; Baldissera E; Dagna L
Scand J Rheumatol; 2015; 44(4):309-14. PubMed ID: 25656459
[TBL] [Abstract][Full Text] [Related]
16. [Infliximab (anti-TNF-alpha) treatment in patients with adult Still's disease. Experience in 2 cases].
Bonilla Hernán MG; Cobo Ibáñez T; de Miguel Mendieta E; Martín-Mola E
An Med Interna; 2004 Jan; 21(1):23-6. PubMed ID: 15195482
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences.
Kraetsch HG; Antoni C; Kalden JR; Manger B
Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii55-7. PubMed ID: 11890655
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Low-Dose Tocilizumab on Relapsing Adult-Onset Still's Disease.
Vandemergel X; Vandergheynst F
Acta Medica (Hradec Kralove); 2016; 59(1):22-5. PubMed ID: 27131353
[TBL] [Abstract][Full Text] [Related]
19. A 21-year-old man with Still's disease with fever, rash, and pancytopenia.
Mehta BM; Hashkes PJ; Avery R; Deal CL
Arthritis Care Res (Hoboken); 2010 Apr; 62(4):575-9. PubMed ID: 20391515
[No Abstract] [Full Text] [Related]
20. Long-term safety of tocilizumab treatment on chronic active hepatitis C in a patient with adult onset Still's disease.
Forestier E; Pasquali JL
Joint Bone Spine; 2015 Mar; 82(2):136-7. PubMed ID: 25553837
[No Abstract] [Full Text] [Related]
[Next] [New Search]
